On-Site Surgical Back-up is ‘Critically’ Important for PCI!

Slides:



Advertisements
Similar presentations
2013 ACCF/AHA/SCAI Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures A Report of the American College of Cardiology.
Advertisements

Allen Jeremias MD MSc, Sanjay Kaul MD, Luis Gruberg MD, Todd K. Rosengart MD, David L. Brown MD Divisions of Cardiovascular Medicine and Cardiothoracic.
CABG VS Multi Vessel PCI Hasanat Sharif MD FRCS Chief of Cardiorthoracic Surgery Aga Khan University Hospital.
The Radial Approach to Percutaneous Coronary Intervention Is Associated With a Lower Risk for Complications Regardless of Radial Procedure Volume: A Report.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Published in Circulation 2005 Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis Demosthenes.
What Do We Mean By Quality In PCI Institutional Requirements Dr Bernard Prendergast John Radcliffe Hospital, Oxford.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
USE OF CITRATED CLOTTING TIME IN MONITORING ENOXAPARIN LEVEL DURING CONTEMPORARY PERCUTANEOUS CORONARY INTERVENTION IN ACUTE CORONARY SYNDROMES B.Y.C.
” “The Dissociation Between Door-to- Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes”
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
National AMI Information Call February 5, 2008 Patient Safety Initiative.
Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,
What’s happened in 2007 and why? Mark de Belder President British Cardiovascular Intervention Society.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
False Positive ST Elevation in Patients Undergoing Direct Percutaneous Coronary Intervention David M. Larson MD, Katie M. Menssen, BS,, Scott W Sharkey.
Chattanooga/TriState Regional Update 2015 Robert L. Huang, MD MPH UT Erlanger Health System.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
? What more will it take to turn the tide of treatment for angina patients from a PCI-first to an optimal medical therapy– first approach? 1.
IABP用于高危PCI有价值吗? Is IABP Valuable for High-Risk PCI?
Dallas 2015 TFQO: Karen Woolfrey #COI 261 EVREV 1: Karen Woolfrey # COI 261 EVREV 2: Daniel Pichel #COI 513 Taskforce: ACS ACS 872: Pre-hospital Diversion.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
No conflicts of interest or financial ties to disclose.
Survival Benefits in Higher Risk Patients Coronary Revascularization has Revolutionized the Therapy of Ischemic Heart Disease Acute coronary syndromes.
Rationale for TOTAL trial: randomized trial of routine aspiration ThrOmbecTomy with PCI vs. PCI ALone in patients with STEMI undergoing primary PCI Sanjit.
Total Occlusion Study of Canada (TOSCA-2) Trial
A Clinical profile of patients enrolled in the Pakistan ACS registry
Clinical Trial Design for Second Generation TAVI - Academic View
Pros and Cons of Radial Access
Venous Thromboembolism Prophylaxis (VTE)
The Importance of Adequately Powered Studies
Final Five-Year Follow-up of the SYNTAX Trial: Optimal Revascularization Strategy in Patients With Three-Vessel Disease and/or Left Main Disease Patrick.
The MASS-DAC Study.
Improving Outcomes in Cardiogenic Shock
PCI related in-hospital mortality based on race and gender in the USA
Talk Title SURGICAL BACK-UP IS NOT REQUIRED FOR PRIMARY PCI
Clinical need for determination of vulnerable plaques
Donald E. Cutlip, MD Beth Israel Deaconess Medical Center
Successful CTO PCI Associated with Lower Mortality Risk
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
Andre Lamy on behalf of the COMPASS Investigators
Transradial Intervention as Access of Choice in STEMI
Is There a Role for Aspiration in STEMI?
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Cardiovacular Research Technologies
Public Reporting of Cardiovascular Data
Considerations for Percutaneous Coronary Intervention (PCI)
Section 5: Intervention and drug therapy
Figure 1 PCI strategies in patients with STEMI and multivessel disease
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The European Society of Cardiology Presented by RJ De Winter
American College of Cardiology Presented by Dr. Michel R. Le May
Global Registry of Acute Coronary Events: GRACE
ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008
A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned  Robert E.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Comparison of radial versus femoral access in patients undergoing invasive management for acute coronary syndromes: evidence from a systematic review and.
DANAMI 3-DEFER Trial design: Patients presenting with STEMI and in whom the operators could establish TIMI 2-3 flow without stenting or those presenting.
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
Atlantic Cardiovascular Patient Outcomes Research Team
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Randomized Controlled Trial’s in a self-improving health system
PowerPoint 16:9 Screen Ratio Template *
Pre-hospital prediction of transmural myocardial infarction and the need of acute coronary reperfusion by an artificial neural network compared to real-time.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

On-Site Surgical Back-up is ‘Critically’ Important for PCI! Jeff Brinker MD, FACC, FSCAI Professor of Medicine and Radiology Johns Hopkins Medical Institutions

Jeff A. Brinker, MD DISCLOSURES I have no real or perceivable conflicts of interest to report.

Does PCI Without On-site Surgery Pass the Mother Test? Or the Mother-in-law Test?

The Inevitable Wave of Change ‘Need For On-Site Surgical Support’ Coronary Angiography Primary PCI Guidelines NSTEMI/Elective PCI

Disclaimer Tom Aversano and the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT) Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery : A Randomized Controlled Trial. JAMA 2002;287:1943 At 6 months better clinical outcome and shorter hospital stay in PCI group. Ongoing RCT: Non-emergent PCI at hospitals without vs with on-site cardiac surgery; 14,000 of target 18,000 patients enrolled.

Is STEMI an Unique Clinical Scenario? STEMI: Emergent situation in which ‘time is muscle’ Goal (limited) is establishment of TIMI 3 flow ASAP High risk for surgery; often 1 or 2 VD Less attractive for surgery Options: Thrombolytics vs PPCI; if PPCI patients triaged to PCI center with CVS on-site patients transferred to PCI center with CVS on-site PPCI at sites without CVS on site Keeley & Grines Ann Intern Med 2004;141:298 ACS: Early medical therapy acceptable Stable hemodynamics/rhythm (or can be stabilized) Higher prevalence of multivessel disease

Why Even Consider PCI Without Surgical Availability? Geographic impediment to receiving tertiary care. Extend care to the underserved. (AHJ 2008;155:668) Ability to provide safer, more effective, or less costly tertiary service. Business opportunity for hospital. Business opportunity for interventionalists. Fear of loss of patient base in competitive environment where similar hospitals are opening PCI programs.

Optimal vs Acceptable vs Unacceptable Assumption: On-site CVS is a component of an ‘Optimal’ environment for PCI. Usually implies: Higher CAD patient volumes Availability of other specialists/subspecialists System redundancy (MDs, staff, resource) Advanced equipment and techniques Assumption: ‘Acceptable’ is risk/benefit dependent. Thus lack of CVS may be acceptable for STEMI but not for non-emergent PCI.

Concerns Is there commitment to fully equip and staff 24/7 PCI facility? The sprouting up of PCI programs at multiple non-CVS community hospitals in close proximity to each other or to an on-site CVS hospital is not sound healthcare policy. Lower volume PCI sites especially when served by low volume operators have less satisfactory patient outcomes. Non-CVS hospitals may be less compliant with guideline-recommended therapy (JACC Intv 2009;2:944) Efforts to increase the case volume to meet mandated minimums provide an incentive to perform marginally indicated procedures.

Fait Accompli Primary PCI at non-CVS sites is current practice around the world and in all but a few states in the U.S. Most states in the U.S. have elective PCI performed at sites without on-site CVS. Large registry data demonstrate no significant differences in mortality or MI (however the low rates of these outcomes and risk variations of patients going to tertiary care centers make this data difficult to interpret) A SCAI consensus document (Cathet Cardiovasc Interv 2007;69:471) has suggested guidelines for the establishment of non-CVS sites elective PCI. Still, there is evidence that low volume PPCI sites lose the advantage over thrombolysis that higher volume PPCI sites have (JAMA 2000;284:3131) and when the former perform PCI for non-primary/rescue purposes there is a higher mortality than in hospitals with on-site CVS (JAMA 2004;292:1961).

Conclusion While on-site surgery doesn’t guarantee optimal PCI, optimal PCI does require on-site surgery. While off-site PPCI and EPCI are here and growth is inevitable; vigilance in quality assurance is not. It remains unclear whether dispersion of PCI will significantly extend appropriate care to underserved or simply redistribute case load increasing low volume facilities.